RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Genetron Holdings Stock

Genetron Holdings Stocks 2024

Genetron Holdings Stocks

154.7 M

Ticker

GTH

ISIN

US37186H1005

WKN

A2P661

In 2024, Genetron Holdings had 154.7 M outstanding stocks, a 0% change from the 154.7 M stocks in the previous year.

The Genetron Holdings Stocks history

YEARNUMBER OF STOCKS (undefined CNY)
2026e154.7
2025e154.7
2024e154.7
2023e154.7
2022154.7
2021153.5
2020100.5
201941.6
201837.9
201730.2

Genetron Holdings shares outstanding

The number of shares was Genetron Holdings in 2023 — This indicates how many shares 154.7 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Genetron Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Genetron Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Genetron Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Genetron Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Genetron Holdings Aktienanalyse

What does Genetron Holdings do?

Genetron Holdings Ltd is a Chinese company that focuses on the development of discoveries in genomic research. They are known for their advanced technologies that allow for the development of cancer diagnostics and personalized therapies. History: Genetron was founded in 2015 by Sizhen Wang, a leading expert in the field of molecular diagnostics. Since then, the company has experienced rapid growth and has become a well-known name in genomic research. In 2019, Genetron Holdings went public on the Beijing Star Board of the Chinese stock exchange. Business model and divisions: The company is divided into two main activities - diagnostics and research. In the diagnostics division, the company focuses on developing personalized medicines for cancer patients. Genetron works closely with hospitals and research institutions throughout China to develop diagnostic tools for cancer prevention. In the research department, the company is involved in the discovery of new genetic markers for various diseases. Genetron utilizes state-of-the-art technologies such as Crispr-Cas9 to edit genes and determine which genes are responsible for which diseases. Products and services: Genetron offers a range of products and services for cancer diagnostics. One of their most well-known products is the Genetron Health System, a platform for personalized medicine. The system uses genetic profiles to identify the best treatment options for patients. Genetron also offers a variety of other diagnostic tests, including tests for ovarian cancer, lung cancer, and stomach cancer. The company also offers a variety of research services. These include genetic studies, the discovery of new medical therapies, and collaboration with other companies in the field of genomic research. Conclusion: Genetron Holdings Ltd is a company with a fascinating history and a unique business model. Their dedication to innovative cancer diagnostics and personalized medicine has helped them become leaders in genomic research. The company offers a wide range of products and services and works closely with the medical community to improve the health and well-being of patients. Genetron Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Genetron Holdings's Shares Outstanding

Genetron Holdings's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Genetron Holdings’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Genetron Holdings’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Genetron Holdings’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Genetron Holdings stock

How many stocks are there of Genetron Holdings?

The current number of stocks of Genetron Holdings is 154.7 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Genetron Holdings are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Genetron Holdings evolved in recent years?

The number of shares of Genetron Holdings has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Genetron Holdings as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Genetron Holdings?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Genetron Holdings pay?

Over the past 12 months, Genetron Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genetron Holdings is expected to pay a dividend of 0 CNY.

What is the dividend yield of Genetron Holdings?

The current dividend yield of Genetron Holdings is .

When does Genetron Holdings pay dividends?

Genetron Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genetron Holdings?

Genetron Holdings paid dividends every year for the past 0 years.

What is the dividend of Genetron Holdings?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genetron Holdings located?

Genetron Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genetron Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genetron Holdings from 10/4/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Genetron Holdings pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Genetron Holdings in the year 2023?

In the year 2023, Genetron Holdings distributed 0 CNY as dividends.

In which currency does Genetron Holdings pay out the dividend?

The dividends of Genetron Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Genetron Holdings

Our stock analysis for Genetron Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genetron Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.